Rapid Therapeutic Financials
| RTSL Stock | USD 0 0.00 0.00% |
Rapid |
Understanding current and past Rapid Therapeutic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Rapid Therapeutic's financial statements are interrelated, with each one affecting the others. For example, an increase in Rapid Therapeutic's assets may result in an increase in income on the income statement.
Rapid Therapeutic Stock Summary
Rapid Therapeutic competes with Bone Biologics, and Tenon Medical. Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc. Rapid Therapeutic operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 8 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US7534311052 |
| Business Address | 5580 Peterson Lane, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.rtslco.com |
| Phone | 800 497 6059 |
| Currency | USD - US Dollar |
Rapid Therapeutic Key Financial Ratios
There are many critical financial ratios that Rapid Therapeutic's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Rapid Therapeutic Science reports annually and quarterly.| Return On Asset | -0.55 | |||
| Revenue | 534 | |||
| Gross Profit | 334 | |||
| Beta | -10.77 | |||
| Z Score | 16.8 |
Rapid Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rapid Therapeutic's current stock value. Our valuation model uses many indicators to compare Rapid Therapeutic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rapid Therapeutic competition to find correlations between indicators driving Rapid Therapeutic's intrinsic value. More Info.Rapid Therapeutic Science is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rapid Therapeutic's earnings, one of the primary drivers of an investment's value.Rapid Therapeutic Science Systematic Risk
Rapid Therapeutic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rapid Therapeutic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Rapid Therapeutic Science correlated with the market. If Beta is less than 0 Rapid Therapeutic generally moves in the opposite direction as compared to the market. If Rapid Therapeutic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rapid Therapeutic Science is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rapid Therapeutic is generally in the same direction as the market. If Beta > 1 Rapid Therapeutic moves generally in the same direction as, but more than the movement of the benchmark.
Rapid Therapeutic November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Rapid Therapeutic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rapid Therapeutic Science. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rapid Therapeutic Science based on widely used predictive technical indicators. In general, we focus on analyzing Rapid Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rapid Therapeutic's daily price indicators and compare them against related drivers.
| Information Ratio | 0.082 | |||
| Maximum Drawdown | 210.0 |
Other Information on Investing in Rapid Pink Sheet
Rapid Therapeutic financial ratios help investors to determine whether Rapid Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rapid with respect to the benefits of owning Rapid Therapeutic security.